Annual SG&A
$163.48M$17.39M+11.90%
Summary
- Current Value
- As of today, XERS annual SG&A is $163.48M, up +11.90% on
- Historical Performance
- XERS annual SG&A is up +30.04% over the past 3 years, and up +159.24% over the past 5 years
- All-Time High Comparison
- XERS annual SG&A is currently at its all-time high
- 3-Year Low Comparison
- XERS annual SG&A is +18.68% above its 3-year low of $137.75M reached on an earlier date
- Sector Comparison
- XERS annual SG&A is higher than 87.57% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $163.48M | +11.9% | +30.0% | +159.2% | +3926.6% | |
| Quarterly SG&A | $46.46M | +3.3% | +34.7% | +181.8% | +3364.5% | |
| TTM SG&A | -$2.72B | -1789.3% | -1825.2% | -3659.2% | -10000.0% | |
| Price | $7.21 | +115.2% | +586.7% | +24.3% | – | |
| Annual Operating Expenses | $199.88M | +11.5% | +32.0% | +61.9% | +1298.0% | |
| Annual Operating Profit | -$33.65M | +23.6% | +70.8% | +72.5% | -154.3% | |
| Annual D&A | $12.63M | -4.1% | +571.9% | +1071.2% | +10000.0% | |
| Annual Revenue | $203.07M | +23.9% | +309.5% | +7360.3% | +10000.0% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $163.48M | at high | |
| 5Y | $163.48M | at high | |
| All | $163.48M | at high |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $137.75M | N/A | +18.7% |
| 5Y | $73.73M | N/A | +121.7% |
| All | $4.06M | +3926.6% |
SG&A History
| Year | Value | Change |
|---|---|---|
| $163.48M | +11.9% | |
| $146.10M | +6.1% | |
| $137.75M | +9.6% | |
| $125.72M | +70.5% | |
| $73.73M | +16.9% |
| Year | Value | Change |
|---|---|---|
| $63.06M | +198.7% | |
| $21.11M | +163.4% | |
| $8.02M | +97.4% | |
| $4.06M | - |
FAQ
What is the current annual SG&A of XERS?
As of today, XERS annual SG&A is $163.48M
What is 1-year change in XERS annual SG&A?
XERS annual SG&A is up +11.90% year-over-year
What is 3-year change in XERS annual SG&A?
XERS annual SG&A is up +30.04% over the past 3 years
How far is XERS annual SG&A from its all-time high?
XERS annual SG&A is currently at its all-time high
How does XERS annual SG&A rank versus sector peers?
XERS annual SG&A is higher than 87.57% of companies in Healthcare sector
When is XERS next annual earnings release?
The next annual earnings release for XERS is on
Quarterly SG&A
$46.46M$2.07M+4.65%
Summary
- Current Value
- As of today, XERS quarterly SG&A is $46.46M, up +4.65% on
- Historical Performance
- XERS quarterly SG&A is up +3.31% year-over-year, and up +34.70% over the past 3 years
- All-Time High Comparison
- XERS quarterly SG&A is currently -14.25% below its historical high of $54.18M set on
- 3-Year Low Comparison
- XERS quarterly SG&A is +38.25% above its 3-year low of $33.61M reached on
- Sector Comparison
- XERS quarterly SG&A is higher than 85.56% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $46.46M | +4.7% | +3.3% | +34.7% | +181.8% | |
| Annual SG&A | $163.48M | – | +11.9% | +30.0% | +159.2% | |
| TTM SG&A | -$2.72B | -1666.6% | -1789.3% | -1825.2% | -3659.2% | |
| Price | $7.21 | -12.9% | +115.2% | +586.7% | +24.3% | |
| Quarterly Operating Expenses | $53.94M | +2.9% | +6.1% | +33.3% | +179.8% | |
| Quarterly Operating Profit | $6.73M | +50.2% | +152.2% | +136.0% | +152.0% | |
| Quarterly D&A | $3.19M | +0.8% | +2.1% | +3.8% | +732.6% | |
| Quarterly Revenue | $74.38M | +4.0% | +37.1% | +150.2% | +687.3% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $46.46M | at high | |
| 3Y | $46.46M | at high | |
| 5Y | $54.18M | -14.3% | |
| All | $54.18M | -14.3% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $40.14M | N/A | +15.8% |
| 3Y | $33.61M | +38.3% | |
| 5Y | $18.00M | N/A | +158.1% |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of XERS?
As of today, XERS quarterly SG&A is $46.46M
What is XERS quarterly SG&A most recent change?
XERS quarterly SG&A was up +4.65% on September 30, 2025
What is 1-year change in XERS quarterly SG&A?
XERS quarterly SG&A is up +3.31% year-over-year
How far is XERS quarterly SG&A from its all-time high?
XERS quarterly SG&A is currently -14.25% below its historical high of $54.18M set on December 31, 2021
How does XERS quarterly SG&A rank versus sector peers?
XERS quarterly SG&A is higher than 85.56% of companies in Healthcare sector
When is XERS next earnings release?
The next earnings release for XERS is on
TTM SG&A
-$2.72B$15.64M-0.58%
Summary
- Current Value
- As of today, XERS TTM SG&A is -$2.72B, down -0.58% on
- Historical Performance
- XERS TTM SG&A is down -1789.35% year-over-year, and down -1825.20% over the past 3 years
- All-Time High Comparison
- XERS TTM SG&A is currently -4386.82% below its historical high of -$60.59M set on an earlier date
- 3-Year Low Comparison
- XERS TTM SG&A is at its 3-year low
- Sector Comparison
- XERS TTM SG&A is higher than 19.32% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$2.72B | -1666.6% | -1789.3% | -1825.2% | -3659.2% | |
| Annual SG&A | $163.48M | – | +11.9% | +30.0% | +159.2% | |
| Quarterly SG&A | $46.46M | +4.7% | +3.3% | +34.7% | +181.8% | |
| Price | $7.21 | -12.9% | +115.2% | +586.7% | +24.3% | |
| TTM Operating Profit | $9.80M | +199.8% | +121.7% | +109.4% | +110.2% | |
| TTM D&A | $12.63M | +0.5% | -1.0% | +25.5% | +801.4% | |
| TTM Revenue | $266.14M | +8.2% | +42.0% | +170.1% | +1659.3% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$2.63B | N/A | -3.5% |
| 3Y | -$2.11B | N/A | -28.8% |
| 5Y | -$1.23B | N/A | -121.4% |
| All | -$60.59M | N/A | -4386.8% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$2.72B | N/A | at low |
| 3Y | -$2.72B | N/A | at low |
| 5Y | -$2.72B | N/A | at low |
| All | -$2.72B | N/A | at low |
TTM SG&A History
FAQ
What is the current TTM SG&A of XERS?
As of today, XERS TTM SG&A is -$2.72B
What is XERS TTM SG&A most recent change?
XERS TTM SG&A was down -0.58% on September 30, 2025
What is 1-year change in XERS TTM SG&A?
XERS TTM SG&A is down -1789.35% year-over-year
How does XERS TTM SG&A rank versus sector peers?
XERS TTM SG&A is higher than 19.32% of companies in Healthcare sector
When is XERS next earnings release?
The next earnings release for XERS is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- XERS Official Website www.xerispharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1867096/000186709625000159/0001867096-25-000159-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1867096/000186709625000039/0001867096-25-000039-index.htm
- XERS Profile on Yahoo Finance finance.yahoo.com/quote/XERS
- XERS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/xers